Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocky G Gogliotti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|September 17, 2010
Cpd-1 null mice display a subtle neurological phenotypeRupinder K Kular, Rocky G Gogliotti, Puneet Opal
Journal of Child Neurology|September 1, 2007
SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?Christopher R Heier, Rocky G Gogliotti, Christine J DiDonato
Biochemical and Biophysical Research Communications|December 8, 2009
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophyRocky G Gogliotti, Suzan M Hammond, Cathleen Lutz, et al.
Neurobiology of Disease|March 15, 2011
Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB/N miceRocky G Gogliotti, Cathleen Lutz, Michael Jorgensen, et al.
Plos One|January 21, 2011
Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not lateSuzan M Hammond, Rocky G Gogliotti, Vamshi Rao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunctionRocky G Gogliotti, Katharina A Quinlan, Courtenay B Barlow, et al.
Human Molecular Genetics|January 8, 2008
Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effectTatiana O Gavrilina, Vicki L McGovern, Eileen Workman, et al.
Human Molecular Genetics|June 6, 2013
The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse modelsRocky G Gogliotti, Herminio Cardona, Jasbir Singh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|September 17, 2010
Cpd-1 null mice display a subtle neurological phenotypeRupinder K Kular, Rocky G Gogliotti, Puneet Opal
Journal of Child Neurology|September 1, 2007
SMN transcript stability: could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?Christopher R Heier, Rocky G Gogliotti, Christine J DiDonato
Biochemical and Biophysical Research Communications|December 8, 2009
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophyRocky G Gogliotti, Suzan M Hammond, Cathleen Lutz, et al.
Neurobiology of Disease|March 15, 2011
Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB/N miceRocky G Gogliotti, Cathleen Lutz, Michael Jorgensen, et al.
Plos One|January 21, 2011
Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not lateSuzan M Hammond, Rocky G Gogliotti, Vamshi Rao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunctionRocky G Gogliotti, Katharina A Quinlan, Courtenay B Barlow, et al.
Human Molecular Genetics|January 8, 2008
Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effectTatiana O Gavrilina, Vicki L McGovern, Eileen Workman, et al.
Human Molecular Genetics|June 6, 2013
The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse modelsRocky G Gogliotti, Herminio Cardona, Jasbir Singh, et al.
Pageof 1